Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroblastoma × spartalizumab × Clear all

Sponsor

Conditions

Melanoma 7 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 3 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1

Interventions

Cyclophosphamide 20 Isotretinoin 14 Topotecan 12 Irinotecan 12 Etoposide 12 Temozolomide 10 Doxorubicin 10 dinutuximab 9 Magnetic Resonance Spectroscopy 9 sargramostim 8 Vincristine 8 Melphalan 8 Filgrastim 7 Cisplatin 7 Granulocyte-Macrophage Colony-Stimulating Factor 6 Granulocyte Colony-Stimulating Factor 6 3-Iodobenzylguanidine 6 Specimen Handling 5 Carboplatin 5 fludarabine 4 etoposide phosphate 4 aldesleukin 4 X-Rays 4 Stem Cell Transplantation 4 Radiotherapy 4 Phantoms, Imaging 4 Mesna 4 Colony-Stimulating Factors 4 Busulfan 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡